Muh-Yong Yen Selected Research

Muh-Yong Yen Research Topics

Disease

9	Infections 09/2021 - 09/2002
4	COVID-19 09/2021 - 06/2020
2	Sepsis (Septicemia) 10/2022 - 09/2002
2	Human Influenza (Influenza) 08/2022 - 11/2011
2	Meningitis 04/2022 - 01/2021
2	Pneumococcal Infections 04/2022 - 01/2021
2	Latent Tuberculosis 10/2021 - 07/2013
2	Pneumonia (Pneumonitis) 10/2015 - 10/2005
2	Bacteremia 10/2015 - 02/2010
2	HIV Infections (HIV Infection) 07/2014 - 11/2012
2	Neoplasms (Cancer) 01/2014 - 05/2012
2	Urinary Tract Infections (Urinary Tract Infection) 04/2011 - 09/2002
2	Bacterial Infections (Bacterial Infection) 03/2009 - 09/2002
2	Liver Abscess 02/2003 - 09/2002
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 04/2022
1	Cognitive Dysfunction 01/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Community-Acquired Infections 09/2019
1	Gonorrhea 10/2016
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 02/2016
1	Inflammation (Inflammations) 02/2016
1	Gastroenteritis 01/2016
1	Substance-Related Disorders (Drug Abuse) 07/2014
1	Adenocarcinoma of Lung 01/2014
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Coinfection 12/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2012
1	Drug-Related Side Effects and Adverse Reactions 11/2011
1	Herpesviridae Infections (Herpesvirus Infection) 11/2011
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2010
1	Cross Infection (Nosocomial Infection) 07/2008
1	Legionnaires' Disease (Legionnaire's Disease) 07/2008
1	Aneurysm (Aneurysms) 08/2005

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 03/2009
5	Methadone (Dolophine)FDA LinkGeneric 07/2014 - 04/2011
3	Carbapenems (Carbapenem Antibiotics)IBA 10/2022 - 09/2019
3	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2022 - 11/2010
2	eravacyclineIBA 10/2022 - 01/2021
2	Cefepime (Maxipime)FDA LinkGeneric 10/2022 - 09/2002
2	omadacyclineIBA 10/2022 - 01/2021
2	SuspensionsIBA 08/2022 - 08/2010
2	Linezolid (Zyvox)FDA Link 04/2022 - 01/2021
2	Vancomycin FDA LinkGeneric 04/2022 - 01/2021
2	Moxifloxacin (Avelox)FDA Link 04/2022 - 01/2021
2	Cefixime (Suprax)FDA Link 10/2016 - 11/2010
2	Volatile Oils (Essential Oils)IBA 02/2016 - 01/2014
2	Cefazolin (Ancef)FDA LinkGeneric 02/2010 - 09/2002
2	Gentamicins (Gentamicin)FDA LinkGeneric 02/2010 - 09/2002
1	enmetazobactamIBA 10/2022
1	CefiderocolIBA 10/2022
1	cefepime-zidebactamIBA 10/2022
1	AntibodiesIBA 08/2022
1	Penicillins (Penicillin)FDA Link 04/2022
1	Doripenem FDA Link 04/2022
1	Ertapenem (Invanz)FDA Link 04/2022
1	Levofloxacin (Levaquin)FDA Link 04/2022
1	QuinolonesIBA 04/2022
1	Hand SanitizersIBA 09/2021
1	TeicoplaninIBA 01/2021
1	Conjugate VaccinesIBA 01/2021
1	Ceftaroline FDA Link 01/2021
1	dalbavancinIBA 01/2021
1	quinupristin-dalfopristin (Synercid)FDA Link 01/2021
1	tedizolidIBA 01/2021
1	telavancin FDA Link 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	Illicit Drugs (Recreational Drugs)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016
1	TeaIBA 02/2016
1	Interleukin-4 (Interleukin 4)IBA 02/2016
1	CytokinesIBA 02/2016
1	AntacidsIBA 01/2016
1	Colistin (Coly-Mycin)FDA Link 10/2015
1	Tigecycline (Tygacil)FDA Link 10/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2014
1	beta-thujaplicinIBA 01/2014
1	Gefitinib (Iressa)FDA Link 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	Tuberculin (PPD)IBA 07/2013
1	Amphetamine (Amfetamine)FDA LinkGeneric 12/2012
1	AcidsIBA 05/2012
1	Antiviral Agents (Antivirals)IBA 11/2011
1	peramivirIBA 11/2011
1	Neuraminidase (Sialidase)IBA 11/2011
1	Oseltamivir (Tamiflu)FDA Link 11/2011
1	Morphine (MS Contin)FDA LinkGeneric 04/2011
1	FluoroquinolonesIBA 04/2011
1	Drinking WaterIBA 07/2008

Therapy/Procedure

5	Therapeutics 10/2015 - 09/2002
3	Long-Term Care 10/2021 - 06/2020
1	Hand Hygiene 09/2021
1	Injections 10/2016
1	Condoms (Condom) 10/2016
1	Length of Stay 10/2015
1	Mechanical Ventilators (Ventilator) 10/2015
1	Oral Administration 11/2011
1	Intravenous Infusions 11/2011
1	Duration of Therapy 04/2011
1	Ligation 08/2005